XML 42 R18.htm IDEA: XBRL DOCUMENT v3.19.1
Intangible assets and goodwill
12 Months Ended
Dec. 31, 2018
Disclosure Of Reconciliation Of Changes In Intangible Assets And Goodwill [Abstract]  
Intangible assets and goodwill

13.

Intangible assets and goodwill

 

 

 

 

 

 

 

 

(a)

Intangible assets

 

 

Cost

As at

January 1, 2017

 

 

Additions

 

 

As at

December 31, 2017

 

 

Additions

 

 

As at

December 31, 2018

 

Software

$

-

 

 

$

-

 

 

$

-

 

 

$

360

 

 

$

360

 

Health Canada Licenses - OGBC

 

1,611

 

 

 

-

 

 

 

1,611

 

 

 

-

 

 

 

1,611

 

Health Canada Licenses - Peace Naturals

 

9,596

 

 

 

-

 

 

 

9,596

 

 

 

-

 

 

 

9,596

 

Israeli Code - Cronos Israel G.S. Cultivations Ltd. (i)

 

-

 

 

 

-

 

 

 

-

 

 

 

156

 

 

 

156

 

Israeli Code - Cronos Israel G.S. Manufacturing Ltd. (i)

 

-

 

 

 

-

 

 

 

-

 

 

 

218

 

 

 

218

 

 

$

11,207

 

 

$

-

 

 

$

11,207

 

 

$

734

 

 

$

11,941

 

 

(i)

Israeli Codes were transferred by non-controlling interests to Cronos Israel in exchange for their equity interests in the Cronos Israel entities specified above. Refer to Note 14. Thus, these capital contributions are considered non-cash additions and have been excluded from the consolidated statement of cash flows.

 

Accumulated amortization

As at

January 1, 2017

 

 

Additions

 

 

As at

December 31, 2017

 

 

Additions

 

 

As at

December 31, 2018

 

Software

$

-

 

 

$

-

 

 

$

-

 

 

$

73

 

 

$

73

 

Health Canada Licenses - OGBC

 

-

 

 

 

-

 

 

 

-

 

 

 

101

 

 

 

101

 

Health Canada Licenses - Peace Naturals

 

-

 

 

 

-

 

 

 

-

 

 

 

533

 

 

 

533

 

 

$

-

 

 

$

-

 

 

$

-

 

 

$

707

 

 

$

707

 

Net book value

$

11,207

 

 

 

 

 

 

$

11,207

 

 

 

 

 

 

$

11,234

 

 

(b)

Goodwill

 

 

As at

January 1, 2017

 

 

Additions

 

 

As at

December 31, 2017

 

 

Additions

 

 

As at

December 31, 2018

 

OGBC

$

392

 

 

$

-

 

 

$

392

 

 

$

-

 

 

$

392

 

Peace Naturals

 

1,400

 

 

 

-

 

 

 

1,400

 

 

 

-

 

 

 

1,400

 

 

$

1,792

 

 

$

-

 

 

$

1,792

 

 

$

-

 

 

$

1,792

 

 


13.

Intangible assets and goodwill (continued)

 

(c)

Impairment

 

For purposes of impairment testing, intangible assets with an indefinite life and goodwill were allocated to the smallest identifiable group of assets that generate cash flows independently (a cash-generating unit or "CGU"). For the year ended December 31, 2018, there were no intangible assets with an indefinite life. Refer to Note 6(a). The Health Canada licenses issued to OGBC and Peace Naturals enable the entities to produce and sell dry cannabis and cannabis oils under the Cannabis Act, enabling the generation of cash flows through the ultimate sale thereof. In order for these licenses to generate such cash flows, the entities need to have the following resources including, but not limited to, the appropriate production facilities, skilled labour, and materials. As such, the Company has assessed that the smallest aggregation of assets that generate independent cash flows would be all of the assets and liabilities of each individual entity for their corresponding license.

 

The recoverable amounts of the CGUs were determined based on a value-in-use calculation, determined using a five-year cash flow projection. The cash flows were estimated using forecasted earnings before interest, taxes, depreciation, and amortization ("EBITDA") less capital expenditures. The key assumptions used in the estimation of the recoverable amounts were as follows:

 

 

OGBC

 

 

Peace Naturals

 

Weighted average cost of capital (after-tax)

12%

 

 

12%

 

Average growth rate*

0%

 

 

14%

 

 

* The average growth rate is the annualized average of the expected year-over-year growth rate (in EBITDA) over five years.

 

These assumptions are based on the Company’s historical results, the preliminary results of the first quarter of the following fiscal year, and management’s expectations of the cash flows based on budgeted results, taking into account estimated sales volume and price changes. The impairment test performed resulted in no impairment of goodwill at December 31, 2018 and no impairment of goodwill or indefinite life intangible assets at December 31, 2017.

 

 

 

 

 

Management has not identified a reasonably possible change in these key assumptions that could cause the carrying amount of either CGU to exceed its recoverable amount.